rs142034206
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BS1_Supporting
The NM_024537.4(CARS2):c.563C>T(p.Thr188Met) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000723 in 1,578,396 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T188A) has been classified as Uncertain significance.
Frequency
Consequence
NM_024537.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CARS2 | NM_024537.4 | c.563C>T | p.Thr188Met | missense_variant | 5/15 | ENST00000257347.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CARS2 | ENST00000257347.9 | c.563C>T | p.Thr188Met | missense_variant | 5/15 | 1 | NM_024537.4 | P1 |
Frequencies
GnomAD3 genomes ? AF: 0.000292 AC: 44AN: 150892Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000294 AC: 71AN: 241100Hom.: 0 AF XY: 0.000360 AC XY: 47AN XY: 130552
GnomAD4 exome AF: 0.000768 AC: 1097AN: 1427504Hom.: 0 Cov.: 29 AF XY: 0.000745 AC XY: 530AN XY: 711436
GnomAD4 genome ? AF: 0.000292 AC: 44AN: 150892Hom.: 0 Cov.: 32 AF XY: 0.000245 AC XY: 18AN XY: 73564
ClinVar
Submissions by phenotype
Combined oxidative phosphorylation defect type 27 Pathogenic:1Uncertain:4
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Nov 27, 2019 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Invitae | Sep 01, 2022 | This sequence change replaces threonine, which is neutral and polar, with methionine, which is neutral and non-polar, at codon 188 of the CARS2 protein (p.Thr188Met). This variant is present in population databases (rs142034206, gnomAD 0.05%). This missense change has been observed in individual(s) with epilepsy and intellectual disability (PMID: 30139652). ClinVar contains an entry for this variant (Variation ID: 475631). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C15"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Mar 17, 2022 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Baylor Genetics | Mar 13, 2020 | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Sep 16, 2021 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Oct 30, 2023 | Variant summary: CARS2 c.563C>T (p.Thr188Met) results in a non-conservative amino acid change located in the tRNA synthetases class I, catalytic domain (IPR032678) of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00029 in 241100 control chromosomes (gnomAD). c.563C>T has been reported in the literature in individuals affected with Alpers-Huttenlocher syndrome (Samanta_2018, Almubarak_2022). These data do not allow any conclusion about variant significance. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 36360262, 34690748, 34426522, 30139652). Six submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as uncertain significance. - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 19, 2018 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at